Reference
Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) Internet Document : 20 Feb 2024. Available from: URL: https://www.gov.uk/drug-safety-update/pseudoephedrine-very-rare-risk-of-posterior-reversible-encephalopathy-syndrome-pres-and-reversible-cerebral-vasoconstriction-syndrome-rcvs
Rights and permissions
About this article
Cite this article
Pseudoephedrine-related PRES and RCVS. Reactions Weekly 1998, 3 (2024). https://doi.org/10.1007/s40278-024-53847-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-53847-x